Drug
Gallium Ga 68 dotatate clinical trials
Also written 68Ga-DOTATATE.
Keep track of what changes. Save the gallium Ga 68 dotatate studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
24 studies that test it; most in 2013 (3)
| Year | Studies |
|---|---|
| 1993 | 1 |
| 2011 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 22
Peking Union Medical College Hospital (4) · First Affiliated Hospital of Fujian Medical University (2) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · Stanford University (1) · Mayo Clinic (1) · HTA Co., Ltd. (1) · Jiangsu HengRui Medicine Co., Ltd. (1) · Radio Isotope Therapy of America (1)
Often tested with
Tested in the same studies.
Ga(III)-DOTATOC (3) · Lutetium Lu 177 dotatate (1) · 68Ga-FAPI (1) · Pentetreotide (1) · Satoreotide tetraxetan gallium GA-68 (1)
Studies
Open first, then newest update. How each study uses gallium Ga 68 dotatate is read from its arms, and is right about nine times in ten.
Testing it · 24
- Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing SyndromeRecruitingPhase 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT02019706Written as 68Ga-DOTATATE
- Ultralow Dose PET Imaging of SSTR2 Radiotracer UptakeRecruitingPhase 2Akiva MintzNCT07284589Written as 68Ga-Dotatate
- Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and ParagangliomaRecruitingNot applicablePeking Union Medical College HospitalNCT07288931Written as Diagnostic Test: 68Ga-DOTATATE
- Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast CancerRecruitingPhase 3University Hospital, GrenobleNCT06611891Written as 68Ga-DOTATOC
- Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid CarcinomaRecruitingPhase 1First Affiliated Hospital of Fujian Medical UniversityNCT06520319Written as 68Ga-MGS5
- Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOCWithdrawnPhase 2Weill Medical College of Cornell UniversityNCT04298541Written as Ga-68-DOTATOC
- Study of PRRT in Metastatic, WHO Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive SurgeryActive, not recruitingPhase 1Stanford UniversityNCT04609592Written as Gallium 68 Dotatate
- Gallium (68Ga) Edotreotide PET/CT for Imaging Patients With Gastrointestinal Pancreatic Neuroendocrine TumorsCompletedPhase 3Jiangsu HengRui Medicine Co., Ltd.NCT06091748Written as 68Ga-DOTATOC
- An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine TumorsActive, not recruitingEarly Phase 1Mayo ClinicNCT04040088Written as Gallium Ga 68-DOTATATE
- Evaluate the Diagnostic Efficacy, Pharmacokinetics and Safety of 68Ga-DOTATATE Injection PET/CT in NETsActive, not recruitingPhase 3HTA Co., Ltd.NCT07119242Written as 68Ga-DOTATATE Injection
- 68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)CompletedNot applicableRadio Isotope Therapy of AmericaNCT01879657Written as 68Ga-DOTATATE
- Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate CancerCompletedPhase 2Emory UniversityNCT03448458Written as Gallium Ga 68-DOTATATE
- Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's PerspectiveCompletedEarly Phase 1Jonsson Comprehensive Cancer CenterNCT01873248Written as 68Ga-DOTATATE
- A Head-to-head Comparison of [68Ga]Ga-FAPI and [68Ga]Ga-TATE PET/CT in Patients With Nasopharyngeal Carcinoma: a Single-center, Prospective StudyCompletedPhase 1/2First Affiliated Hospital of Fujian Medical UniversityNCT05990998Written as 68Ga-DOTATATE and 68Ga-FAPI
- Diagnosis and Staging of Neuroendocrine Tumors (NETs) Utilizing 68Ga-DOTATOC PET/CT ScanCompletedPhase 3Montefiore Medical CenterNCT03136328Written as 68Ga-DOTATOC
- Studies of Elevated Parathyroid ActivityCompletedPhase 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT00001277Written as 68Ga-Dotatate
- Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CTCompletedPhase 2Sue O'DorisioNCT01869725Written as gallium Ga 68-edotreotide
- 68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine TumorsTerminatedEarly Phase 1M.D. Anderson Cancer CenterNCT03001349Written as Gallium Ga 68-Edotreotide
- Application of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in the Diagnosis and Evaluation of TIOStatus unknownPhase 1Peking Union Medical College HospitalNCT04689893Written as 68Ga-Dotatate
- Somatostatin Receptor Imaging in Patients With Suspected Cardiac SarcoidosisCompletedNot applicableMarcelo F. Di Carli, MD, FACCNCT02546388Written as Gallium-68 DOTATATE
See all 24 studies that test gallium Ga 68 dotatate →
Given in every arm · 5 — gallium Ga 68 dotatate is usual care beside what is tested
- Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand TherapyRecruitingPhase 1/2National Cancer Institute (NCI)NCT06427798Written as 68Ga-DOTATATE
- [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck CancersRecruitingPhase 1National Cancer Institute (NCI)NCT06479811Written as 68Ga-DOTATATE
- Al18F-NOTA-LM3 PET/CT in Patients With TIORecruitingNot applicablePeking Union Medical College HospitalNCT07366099Written as Diagnostic Test: 68Ga-DOTATATE
- 18F-MFBG PET/CT in the Evaluation of Neural Crest TumorRecruitingEarly Phase 1Peking Union Medical College HospitalNCT05069220Written as 68Ga-Dotatate
- Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine TumorCompletedEarly Phase 1Thomas HopeNCT03197012Written as 68Ga-DOTA-TOC
Codes
What other systems call gallium Ga 68 dotatate · ClinicalTrials.gg INT004966
- MeSH (NLM) C513399gallium Ga 68 dotatateConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 9L17Y0H71PGALLIUM OXODOTREOTIDE GA-68Confirmed FDA, NLM
- RxNorm 676679One source FDA
- NCI Thesaurus C97661Gallium Ga 68-DOTATATEOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C513399 | gallium Ga 68 dotatate | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 9L17Y0H71P | GALLIUM OXODOTREOTIDE GA-68 | Confirmed FDA, NLM |
| RxNorm | 676679 | — | One source FDA |
| NCI Thesaurus | C97661 | Gallium Ga 68-DOTATATE | One source FDA |
Also registered as edotreotide gallium ga-68 (UNII Y68179SY2L · RxNorm 2199391).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.